<DOC>
<DOCNO>
EP-0013138
</DOCNO>
<TEXT>
<DATE>
19800709
</DATE>
<IPC-CLASSIFICATIONS>
C07D-451/00 A61K-31/395 C07D-471/00 C07D-451/14 C07D-487/00 C07D-487/08 C07D-471/08 <main>C07D-451/04</main> C07D-451/02 C07D-451/04 
</IPC-CLASSIFICATIONS>
<TITLE>
azabicycloalkyl derivatives, a process for their preparation and pharmaceutical compositions containing them.
</TITLE>
<APPLICANT>
beecham group plcgb<sep>beecham group plc<sep>beecham group plcbeecham house, great west roadbrentford, middlesex tw8 9bdgb<sep>beecham group plc<sep>
</APPLICANT>
<INVENTOR>
hadley michael stewart<sep>king francis david<sep>hadley, michael stewart<sep>king, francis david<sep>hadley, michael stewart15 elmwoodsawbridgeworth, hertfordshiregb<sep>king, francis david67 cherry garden lanenewport, essexgb<sep>hadley, michael stewart<sep>king, francis david<sep>hadley, michael stewart15 elmwoodsawbridgeworth, hertfordshiregb<sep>king, francis david67 cherry garden lanenewport, essexgb<sep>
</INVENTOR>
<ABSTRACT>
a compound of the formula (i), and pharmaceutically  acceptable salts thereof:    wherein:   r₁ is a c₁₋₆ alkoxy group;   r₂ and r₃ are the same or different and are hydrogen,  halogen, cf₃, c₂₋₇ acyl, c₂₋₇ acylamino, or amino, aminocar­ bonyl or aminosulphone optionally substituted by one or two  c₁₋₆ alkyl groups, c₁₋₆ alkylsulphone or nitro;   r₅ is hydrogen or c₁₋₆ alkyl;   r₆ is c₁₋₇ alkyl or a group -(ch₂)sr₇ where s is 0 to 2 and r₇ is  a c₃₋₈ cycloalkyl group, or a group -(ch₂)trs where t is 1 or 2  and rs is c₂₋₅ alkenyl or a phenyl group optionally substituted  by one or two substituents selected from c₁₋₆ alkyl, c₁₋₄  alkoxy, trifluoromethyl and halogen; and   n, p and q are independently 0 to 2; have useful phar­ macological activity.  
</ABSTRACT>
</TEXT>
</DOC>
